NCT07668596

Brief Summary

The study consist of 3 interventional periods which will be completed by each consenting participant in a randomized, crossover fashion. The interventional periods will be separated by a minimum 1 week washout period. One of the interventions consists of 4 days of daily supplementation with the commercially available broccoli sprout extract capsules (BrocElite). Another intervention will consist of 4 days of daily supervised treadmill running. The exercise protocol consists of 4 minutes of high-intensity running running followed by a 3 minute recovery period, repeated for a total of 4 repetitions. The last intervention combines the above two and consists of 4 days of daily supplementation and daily supervised exercise training. Before and after each intervention, basic anthropometrics (weight, heart rate, and blood pressure) will be recorded, and a venous blood sample will be collected. Blood samples will be analyzed for metabolic and inflammatory markers. Participants will be asked to refrain from structured exercise, alcohol consumption, and broccoli consumption during each of the experimental periods. Before any testing, willing participants will provide informed consent, and fill out a few demographic, and lifestyle questionnaires. The study will be conducted at the University of British Columbia in Kelowna, BC, Canada.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
22mo left

Started Mar 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress19%
Mar 2026Jun 2028

Study Start

First participant enrolled

March 1, 2026

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 19, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 25, 2026

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2028

Last Updated

July 17, 2026

Status Verified

July 1, 2026

Enrollment Period

1.8 years

First QC Date

June 19, 2026

Last Update Submit

July 15, 2026

Conditions

Keywords

NutraceuticalsExerciseBioenergeticsImmunometabolismInflammationHigh intensity interval training

Outcome Measures

Primary Outcomes (1)

  • Change in peripheral blood mononuclear cell oxygen consumption rate

    OCR will be measured using a Seahorse Analyzer before and after each 4-day intervention

    0-4 days

Secondary Outcomes (13)

  • TNF-alpha secretion from LPS-stimulated whole blood

    0-4 days

  • Change in percentage of classical monocytes before and after the 6-week intervention

    0-4 days

  • Change in percentage of intermediate monocytes before and after the 4-day intervention

    0-4 days

  • Change in percentage of non-classical monocytes before and after the 4-day intervention

    0-4 days

  • Change in TLR-4 expression on classical monocytes before and after the 4-day intervention

    0-4 days

  • +8 more secondary outcomes

Study Arms (3)

Sulforaphane Supplementation Only

EXPERIMENTAL

In this intervention, participants will consume commercially available broccoli sprout extract capsules daily for 4 days (20 mg/day) . Basic anthropometrics (weight, heart rate, blood pressure) and a venous blood sample (30 mL) will be collected before and after this interventional period.

Dietary Supplement: Sulforaphane-rich Broccoli Sprout Extract

Exercise Only

ACTIVE COMPARATOR

In this intervention, participants will complete supervised exercise sessions daily for 4 days. The exercise intervention consists of interval running on a treadmill which contains 4 cycles of: 4 minutes of intense running (85-95% HRmax) followed by 3 minutes at a slow, easy pace. Basic anthropometrics (weight, heart rate, blood pressure) and a venous blood sample (30 mL) will be collected before and after this interventional period.

Other: High Intensity Interval Treadmill Running

Sulforaphane Supplementation and Exercise

EXPERIMENTAL

In this intervention, participants will consume commercially available broccoli sprout extract tablets daily for 4 days. In addition, participants will complete supervised exercise sessions daily for 4 days. The exercise intervention consists of interval running on a treadmill which contains 4 cycles of: 4 minutes of intense running (85-95% HRmax) followed by 3 minutes at a slow, easy pace. Basic anthropometrics (weight, heart rate, blood pressure) and a venous blood sample (30 mL) will be collected before and after this interventional period.

Dietary Supplement: Sulforaphane-rich Broccoli Sprout ExtractOther: High Intensity Interval Treadmill Running

Interventions

Broc Elite Plus stabilized sulforaphane capsules from Mara Labs

Sulforaphane Supplementation OnlySulforaphane Supplementation and Exercise

4 cycles of: 4 minutes of intense treadmill running (85-95% HR max) followed by 3 minutes of slow, easy running.

Exercise OnlySulforaphane Supplementation and Exercise

Eligibility Criteria

Age19 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • aged between 19 and 35 years
  • not a current smoker
  • physically active based on the Canadian Physical Activity Guidelines (150 minutes of weekly physical activity)

You may not qualify if:

  • a history of cardiometabolic diseases or respiratory diseases (e.g., chronic obstructive pulmonary disease, asthma, diabetes, coronary artery disease)
  • currently following a ketogenic diet
  • body mass index (BMI) over 30 kg/m2
  • unable to read or communicate in English
  • having received a vaccination or experienced an upper respiratory tract infection in the last 4 weeks
  • having donated more than 0.5 L of blood within the last 4 weeks
  • currently pregnant
  • have contraindications to high intensity exercise (assessed using the CSEP Get Active Questionnaire)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Reichwald Health Sciences Centre

Kelowna, British Columbia, V1V 1V7, Canada

RECRUITING

MeSH Terms

Conditions

InflammationMotor Activity

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsBehavior

Central Study Contacts

Hashim Islam Principle Investigator, Ph.D

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Randomized-crossover design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

June 19, 2026

First Posted

June 25, 2026

Study Start

March 1, 2026

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

June 1, 2028

Last Updated

July 17, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

IPD will not be shared to ensure the privacy and confidentiality of participants, in accordance with ethical guidelines and data protection regulations. Additionally, this was not included in the informed consent, which did not cover data sharing or address potential risks of re-identification.

Locations